These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 23160507)

  • 1. Statins and the elderly: recent evidence and current indications.
    Schiattarella GG; Perrino C; Magliulo F; Ilardi F; Serino F; Trimarco V; Izzo R; Amato B; Terranova C; Cardin F; Militello C; Leosco D; Trimarco B; Esposito G
    Aging Clin Exp Res; 2012 Jun; 24(3 Suppl):47-55. PubMed ID: 23160507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid-lowering therapy with statins for the primary and secondary prevention of cardiovascular disease.
    Lardizabal JA; Deedwania P
    Cardiol Clin; 2011 Feb; 29(1):87-103. PubMed ID: 21257102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statin therapy in the elderly: a review.
    Szadkowska I; Stanczyk A; Aronow WS; Kowalski J; Pawlicki L; Ahmed A; Banach M
    Arch Gerontol Geriatr; 2010; 50(1):114-8. PubMed ID: 19217673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Statins with a perspective of lifelong therapy].
    Ertaş FS
    Turk Kardiyol Dern Ars; 2009 Mar; 37 Suppl 2():29-36. PubMed ID: 19404048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)--can C-reactive protein be used to target statin therapy in primary prevention?
    Mora S; Ridker PM
    Am J Cardiol; 2006 Jan; 97(2A):33A-41A. PubMed ID: 16442935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initiation of statin therapy: are there age limits?
    Desai DA; Zakaria S; Ouyang P
    Curr Atheroscler Rep; 2012 Feb; 14(1):17-25. PubMed ID: 22086344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuation of statin therapy and primary prevention of nonfatal cardiovascular events.
    Shalev V; Goldshtein I; Porath A; Weitzman D; Shemer J; Chodick G
    Am J Cardiol; 2012 Dec; 110(12):1779-86. PubMed ID: 23021514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statin Prescribing in the Elderly: Special Considerations.
    Leya M; Stone NJ
    Curr Atheroscler Rep; 2017 Oct; 19(11):47. PubMed ID: 29019063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [STATINS FOR THE PREVENTION OF CARDIOVASCULAR DISEASE AND DIABETES INCIDENCE--THE BENEFITS VERSUS THE RISKS].
    Lavie G; Cohen S
    Harefuah; 2015 Jun; 154(6):382-6, 404. PubMed ID: 26281083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of statin treatment based on cardiovascular outcomes in elderly patients: a standard meta-analysis and Bayesian network analysis.
    Zhai C; Hou K; Li R; Hu Y; Zhang J; Zhang Y; Wang L; Zhang R; Cong H
    J Int Med Res; 2020 Jun; 48(6):300060520926349. PubMed ID: 32529863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The need for wider and appropriate utilization of aspirin and statins in the treatment and prevention of cardiovascular disease.
    Hennekens CH; Schneider WR
    Expert Rev Cardiovasc Ther; 2008 Jan; 6(1):95-107. PubMed ID: 18095910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the impact of the recent controversy over statins in France: the EVANS study.
    Saib A; Sabbah L; Perdrix L; Blanchard D; Danchin N; Puymirat E
    Arch Cardiovasc Dis; 2013 Oct; 106(10):511-6. PubMed ID: 24080324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The statin studies: from targeting hypercholesterolaemia to targeting the high-risk patient.
    Ong HT
    QJM; 2005 Aug; 98(8):599-614. PubMed ID: 16006501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Benefits and risks for primary prevention with statins in the elderly].
    Joseph JP; Afonso M; Berdaï D; Salles N; Bénard A; Gay B; Bonnet F
    Presse Med; 2015 Dec; 44(12 Pt 1):1219-25. PubMed ID: 26585744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapeutic Strategies. Cardiovascular risk and dyslipidemia in elderly and women].
    Morales C; Royuela M
    Clin Investig Arterioscler; 2013; 25(3):146-50. PubMed ID: 23786854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statins in the elderly: an answered question?
    Zoungas S; Curtis A; Tonkin A; McNeil J
    Curr Opin Cardiol; 2014 Jul; 29(4):372-80. PubMed ID: 24866986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statin therapy for the prevention of atrial fibrillation: a meta-analysis of randomized controlled trials.
    Wang Z; Zhang Y; Gao M; Wang J; Wang Q; Wang X; Su L; Hou Y
    Pharmacotherapy; 2011 Nov; 31(11):1051-62. PubMed ID: 22026393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary prevention of cardiovascular mortality and events with statin treatments: a network meta-analysis involving more than 65,000 patients.
    Mills EJ; Rachlis B; Wu P; Devereaux PJ; Arora P; Perri D
    J Am Coll Cardiol; 2008 Nov; 52(22):1769-81. PubMed ID: 19022156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid lowering for secondary prevention of cardiovascular disease in older adults.
    Thomas JE; Tershakovec AM; Jones-Burton C; Sayeed RA; Foody JM
    Drugs Aging; 2010 Dec; 27(12):959-72. PubMed ID: 21087066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary prevention of cardiovascular disease with statins in the elderly.
    Reiner Z
    Curr Atheroscler Rep; 2014 Jul; 16(7):420. PubMed ID: 24781597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.